Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics
07 Décembre 2022 - 10:00PM
Business Wire
Protect the Value of Your Investment by Voting
the WHITE Proxy Card Ahead of
the Special Meeting Scheduled for Friday, December 9th
Camac Partners, LLC, affiliates of Concord Investment Partners
Ltd., and Leonite Capital LLC (collectively with their affiliates,
the “Investor Group” or “we”), who are collectively the largest
external stockholder of Pasithea Therapeutics Corp. (Nasdaq: KTTA)
(“Pasithea” or the “Company”), today issued the below statement
recommending stockholders vote on the WHITE proxy card to remove the Company’s Board
of Directors (the “Board”) at the upcoming Special Meeting of
Stockholders (the “Special Meeting”) scheduled for Friday, December
9th, 2022:
“It is extremely important that Pasithea
stockholders vote their shares on the WHITE proxy card as soon as possible, no
matter how many or few shares you own. The Special Meeting is just
a few days away and we believe that recent concerning actions taken
by Pasithea’s Board — including multiple dilutive acquisitions at
stockholders’ expense — underscore why urgent change is needed in
the boardroom. By removing the Company’s current directors, we
believe Pasithea will finally be positioned to enhance its
corporate governance, improve capital allocation and unlock
significant value for all stockholders.
Protect the value of your investment
TODAY and vote FOR all matters on the WHITE proxy card by telephone, over the
Internet, or by signing, dating and returning your WHITE proxy card in the postage-paid envelope
provided.”
VOTE THE WHITE
PROXY CARD TODAY.
If you have any questions on how to vote
your shares on the WHITE proxy card,
please contact InvestorCom LLC by email at info@investor-com.com or
by telephone at 203-972-9300.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221206006144/en/
For Investors: Concord Investment Partners Ltd. David
Delaney, 416-951-9214 ddelaney@concordinvestmentpartners.com
InvestorCom LLC John Grau, 203-972-9300
info@investor-com.com
For Media: Longacre Square Partners Charlotte Kiaie /
Aaron Rabinovich, 646-386-0091 ckiaie@longacresquare.com /
arabinovich@longacresquare.com
Pasithea Therapeutics (NASDAQ:KTTA)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Pasithea Therapeutics (NASDAQ:KTTA)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025